Senior insider sale
EVP and Chief Legal Officer at ULTRAGENYX PHARMACEUTICAL INC. — senior position signals high conviction
$92.5K
3.80K shares
What this filing means
PARSCHAUER KARAH HERDMAN plans to sell 3.80K shares of ULTRAGENYX PHARMACEUTICAL INC. valued at approximately $92.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/15/2026ACC: 0001950047-26-006115
Officer· EVP and Chief Legal Officer
Since Mar 2026
3.80K
Shares to sell
$92.5K
Approx. market value
3.80K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Performance Stock Units
N/A
3/1/2025
3.80KTotal acquired3.80K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/1/2025 | Performance Stock Units N/A | 3.80K | — |
| Total | 3.80K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
3.80K
Market value
$92.5K
6/15/2026
Total
Units
3.80K
Value
$92.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/15/2026 | 3.80K | $92.5K | NASDAQ | Planned |
| Total | 3.80K | $92.5K | ||